Simon Spichak

More from Simon Spichak

Microsoft's BioGPT AI, designed to answer questions about medicine and biology, claims ghosts are real and vaccines cause autism.

Microsoft Released an AI That Answers Medical Questions, But It’s Wildly Inaccurate

By Simon Spichak

Max Hodak started Neuralink with Elon Musk. But he later left the company and started Science Corp -- and now he's rapidly catching up.

Prosthetics and Devices

Meet the Neuralink Cofounder Who Left and Started a Competitor That’s Now Rapidly Catching Up

By Simon Spichak

NFTs were supposed to help independent artists. Instead, many say that they're forcing to deal with a bunch of new headaches.

Independent Artists Say NFTs Are the Bane of Their Existence

By Simon Spichak

Despite its very recent approval, startups are already lining up to prescribe a new weight loss drug called Wegovy, a tradename for semaglutide.

Health & Medicine

Startups Are Rushing to Prescribe a New Weight Loss Drug, But Questions Remain

By Simon Spichak

A biotech startup helmed by provocative Harvard geneticist George Church has secured $15 million in funding to bring back woolly mammoths.

Science & Energy

George Church Has Raised $15M to Bring an Elephant-Mammoth Hybrid to Life. Could It Actually Work?

By Simon Spichak

Departed Neuralink co-founder Max Hodak is working on what appears to be a well-funded new brain interface venture called Science Corp.

Neuroscience and Brain

Departed Neuralink Co-Founder Locks Down $47 Million for Secretive Neuroscience Startup

By Simon Spichak

Neuralink, Elon Musk's brain-computer interface startup, has been without a president for almost an entire quarter -- and it's unclear what's going on.

Did Elon Musk Quietly Fire the President of Neuralink?

By Simon Spichak